Related Experiment Video
Updated: May 10, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Malignant middle cerebral artery syndrome and decompressive hemicraniectomy after ischaemic stroke
Adam Sheriff1, Benjamin M Davies1, Harry Wj Mee1
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, England, UK.
Abstract:
Malignant middle cerebral artery (MCA) syndrome is one of the most devastating stroke syndromes, occurring in approximately 10% of ischaemic strokes and resulting in high morbidity and mortality (up to 80% if untreated). These outcomes reflect the large volume of infarction and consequent oedema and raised intracranial pressure resulting from a large vessel occlusion. Pharmacological treatment of this syndrome has limited efficacy and surgical management with decompressive hemicraniectomy (DHC) is the mainstay to reduce mortality. Decisions regarding such neurosurgical interventions are nuanced and require a multidisciplinary approach. This review considers the pathophysiology and natural history of malignant MCA stroke, the indications for DHC, technical considerations of craniectomy and cranioplasty, and the importance of clear communication in shared decision-making with patients, families and across specialities.
Insights
Malignant middle cerebral artery (MCA) syndrome, a severe stroke type, has high mortality. Decompressive hemicraniectomy (DHC) is a key surgical treatment to reduce death rates in these critical stroke cases.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Malignant middle cerebral artery (MCA) syndrome is a severe stroke complication with high mortality.
- It results from large vessel occlusion, leading to significant infarction, edema, and increased intracranial pressure.
- Current pharmacological treatments offer limited efficacy for this condition.
Purpose of the Study:
- To review the pathophysiology and natural history of malignant MCA stroke.
- To outline indications and technical aspects of decompressive hemicraniectomy (DHC).
- To emphasize multidisciplinary approaches and communication in managing these stroke patients.
Main Methods:
- Literature review focusing on malignant MCA syndrome.
- Analysis of pathophysiology, natural history, and treatment outcomes.
- Discussion of surgical techniques and decision-making processes.
Main Results:
- Decompressive hemicraniectomy (DHC) is the primary intervention to reduce mortality in malignant MCA stroke.
- Effective management requires a multidisciplinary team approach.
- Shared decision-making with patients and families is crucial.
Conclusions:
- Malignant MCA syndrome necessitates prompt and aggressive management, often involving DHC.
- Successful outcomes depend on coordinated care and clear communication among specialists.
- Further research into optimizing DHC and patient selection is warranted.
More Related Videos
06:54A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology